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Summary
 
We have analyzed transgenic mice carrying versions of a human T cell receptor (TCR)
 
-
 
d 
 
gene
minilocus to study the developmental control of VDJ (variable/diversity/joining) recombina-
tion. Previous data indicated that a 1.4-kb DNA fragment carrying the TCR-
 
d 
 
enhancer (E
 
d
 
)
efﬁciently activates minilocus VDJ recombination in vivo
 
.
 
 We tested whether the transcription
factor CBF/PEBP2 plays an important role in the ability of E
 
d
 
 to activate VDJ recombination
by analyzing VDJ recombination in mice carrying a minilocus in which the 
 
d
 
E3 element of E
 
d
 
includes a mutated CBF/PEBP2 binding site. The enhancer-dependent VD to J step of minilo-
cus rearrangement was dramatically inhibited in three of four transgenic lines, arguing that the
binding of CBF/PEBP2 plays a role in modulating local accessibility to the VDJ recombinase in
vivo. Because mutation of the 
 
d
 
E3 binding site for the transcription factor c-Myb had previ-
ously established a similar role for c-Myb, and because a 60-bp fragment of E
 
d
 
 carrying 
 
d
 
E3 and
 
d
 
E4 binding sites for CBF/PEBP2, c-Myb, and GATA-3 displays significant enhancer activity
in transient transfection experiments, we tested whether this fragment of E
 
d
 
 is sufﬁcient to acti-
vate VDJ recombination in vivo. This fragment failed to efﬁciently activate the enhancer-
dependent VD to J step of minilocus rearrangement in all three transgenic lines examined, indi-
cating that the binding of CBF/PEBP2 and c-Myb to their cognate sites within E
 
d
 
, although
necessary, is not sufﬁcient for the activation of VDJ recombination by E
 
d
 
. These results imply
that CBF/PEBP2 and c-Myb collaborate with additional factors that bind elsewhere within E
 
d
 
to modulate local accessibility to the VDJ recombinase in vivo.
 
T
 
he process of VDJ recombination assembles variable
(V)
 
1
 
, diversity (D), and joining (J) gene segments at
TCR and Ig loci during lymphocyte development, gener-
ating the diverse antigen receptor repertoires that charac-
terize mature T and B lymphocytes (1–5). VDJ recombina-
tion is under stringent developmental control, as it is
activated at individual antigen receptor loci with unique
cell lineage-specific and developmental stage-specific prop-
erties. Thus, fully rearranged TCR genes are only gener-
ated in developing T lymphocytes, and fully rearranged Ig
genes are only generated in developing B lymphocytes.
Further, TCR-
 
b
 
, -
 
g
 
, and
 
 
 
-
 
d 
 
rearrangement occurs earlier
during thymocyte development than TCR-
 
a
 
 rearrange-
ment (6), and IgH rearrangement occurs earlier in B cell
development than Ig
 
k
 
 and 
 
l
 
 rearrangement (1). Because all
of these loci are thought to share both recombination signal
sequences and the known components of the recombinase
machinery, it is generally believed that these factors cannot
account for locus-specific regulation of VDJ recombination.
Rather, it is thought that locus-specific regulation is ac-
complished by modulating the accessibility of chromosomal
recombination substrates to the recombinase (1–5).
The expression of fully rearranged TCR and Ig genes is
controlled by a promoter flanking the V gene segment, and
one or more transcriptional enhancers located adjacent to
the C gene segment (7, 8). Recent studies have indicated
that these 
 
cis
 
-acting elements are also required for the de-
velopmental activation of VDJ recombination at individual
antigen receptor loci. This has been accomplished by elim-
inating, mutating, or substituting enhancer or promoter ele-
ments within chromosomally integrated VDJ recombination
substrates in transgenic mice (9–16), as well as by eliminat-
ing enhancer elements from endogenous antigen receptor
loci by homologous recombination (17–23). These studies
show that the efficiency of VDJ recombination is dramati-
cally inhibited in the absence of a functional enhancer, and
that the developmental activation of VDJ recombination
can be modified by substitution of one enhancer for an-
other.
 
1
 
Abbreviations used in this paper:
 
 D, diversity; J, joining; V, variable.
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We have previously studied the developmental control of
VDJ recombination in transgenic mice carrying a human
TCR-
 
d
 
 gene minilocus (13, 14). Efficient VDJ recombination
of this minilocus requires the presence of E
 
d
 
 within the J
 
d
 
3-C
 
d
 
intron. Interestingly, the first step of minilocus rearrange-
ment, V to D, occurs even in the absence of E
 
d
 
, whereas
the second step of minilocus rearrangement, VD to J, is E
 
d
 
dependent (13). Thus, a functional enhancer is critical for
establishing J segment accessibility to the VDJ recombinase
machinery. Furthermore, substitution of E
 
a
 
 for E
 
d
 
 within
the minilocus reveals that E
 
d
 
 and E
 
a
 
 regulate both the T cell
subset and developmental stage specificity of the VD to J
step of minilocus rearrangement in a manner that mimics
the developmental activation of V
 
d
 
D
 
d
 
J
 
d
 
 and V
 
a
 
J
 
a
 
 rearrange-
ment, respectively, at the endogenous TCR-
 
a
 
/
 
d
 
 locus (14).
These results lead to the conclusion that E
 
d
 
 and E
 
a
 
 are in-
deed responsible for the developmental regulation of VDJ
recombination at the endogenous TCR-
 
a
 
/
 
d
 
 locus.
The developmental properties of E
 
d
 
 and E
 
a
 
 presumably
result from the binding of specific 
 
trans
 
-acting factors to
discrete sites within the enhancers. Therefore, to better un-
derstand the mechanism by which these enhancers control
VDJ recombination, we have begun to introduce muta-
tions into previously defined 
 
cis
 
-acting enhancer elements
within the context of the TCR-
 
d
 
 gene minilocus, and to
measure the effects of these mutations on the process of VDJ
recombination in vivo.
E
 
d
 
 was initially defined and functionally dissected in trans-
ient transfection and in vitro protein binding studies (24–
28). These experiments identified an essential element of
the enhancer, 
 
d
 
E3, that contains adjacent binding sites for
the transcription factors CBF/PEBP2 (29–31) and c-Myb
(32). Intact binding sites for both CBF/PEBP2 (the “core”
site) (25) and c-Myb (27) are required for transcriptional
activation by E
 
d
 
. Because CBF/PEBP2 has been implicated
in TCR-
 
a
 
, -
 
b
 
, and -
 
g
 
 enhancer activity as well (30, 33–
36), it appears to be a crucial and broadly important regula-
tor of T cell development and T cell–specific gene expres-
sion. Mice carrying a homozygous mutation within the
gene encoding one particular CBF/PEBP2 isoform (
 
a
 
B)
display a very early defect in hematopoiesis and early em-
bryonic lethality (37). Although these results clearly dem-
onstrate an important role for CBF/PEBP2 in the develop-
ment of early hematopoietic precursor cells, they do not
provide information regarding subsequent molecular events
that might be regulated by CBF/PEBP2 within developing
thymocytes
 
 
 
in vivo.
The present study was initiated to determine whether
CBF/PEBP2 plays an important role in the developmental
activation of TCR genes in vivo, by specifically testing its
role in the activation of VDJ recombination by E
 
d
 
. We
found that disruption of the 
 
d
 
E3 core site significantly im-
pairs the ability of E
 
d
 
 to activate VDJ recombination within
the TCR-
 
d
 
 gene minilocus, suggesting that CBF/PEBP2 is
an important regulator of VDJ recombination in vivo.
Since previous data had indicated an important role for c-Myb
as well, we then asked whether a small fragment of E
 
d
 
 car-
rying binding sites for these factors as well as GATA-3 was
sufficient to activate VDJ recombination. We found that this
was not the case, arguing that additional 
 
cis
 
-acting elements
of E
 
d
 
 are also required to establish local accessibility to the
VDJ recombinase.
 
Materials and Methods
 
Production of Transgenic Mice.
 
The CBF/PEBP2 binding site
mutation was generated by PCR using as a template the 1.4-kb
wild-type E
 
d
 
 subcloned into the XbaI site of pBluescript KS
 
1
 
(1.4E
 
d
 
BS). PCR overlap extension was performed as described (38)
using mutagenic oligonucleotides ACOREM (AGCAATGCAT-
GACCTTTCCAACCG) and BCOREM (CGGTTGGAAAG-
GTCATGCATTGCT) along with EDRA (CTTTTAAAATTCT-
AGCAAGC) and the reverse primer as outside primers. The final
PCR product was digested with NsiI and BamHI to generate a
170-bp fragment of E
 
d
 
 carrying the 3-bp change in 
 
d
 
E3 that elim-
inates CBF/PEBP2 binding. The plasmid 1.4E
 
d
 
BS was also digested
with PfiMI and NsiI to obtain an adjacent 590-bp fragment of E
 
d
 
.
The two fragments were ligated together into PfiMI and BamHI
cut 1.4E
 
d
 
BS. The structure of the resulting plasmid was deter-
mined by restriction mapping and dideoxynucleotide sequence
analysis. The 1.4-kb E
 
d
 
mCore was excised from this plasmid with
XbaI and cloned into XbaI-digested, phosphatase-treated pBlue-
script carrying the previously described enhancerless minilocus (13).
A minilocus construct containing the 
 
d
 
E3,4 region was gener-
ated as follows. A 60-bp Nsi–AluI fragment of E
 
d
 
 (
 
d
 
E3,4) had
been previously subcloned into PstI and EcoRV cut pBluescript
KS
 
1
 
. The insert was excised from this plasmid by digestion with
BamHI and HindIII and the ends were blunted by treatment with
the Klenow fragment of 
 
Escherichia coli
 
 DNA polymerase I. This
fragment was then ligated into Xba I-digested, blunted, and phos-
phatase-treated pBluescript carrying the enhancerless minilocus.
The structures of both minilocus constructs were confirmed by
dideoxynucleotide sequence analysis.
Minilocus DNA was purified as described previously (13), and
was microinjected into fertilized C57BL/6 
 
3
 
 SJL F2 eggs by the
Duke University Comprehensive Cancer Center Transgenic Mouse
Shared Resource. Progeny tail DNA samples were analyzed on
Southern blots as described previously (13). Transgenes were main-
tained on a mixed C57BL/6 
 
3
 
 SJL background. Copy number
was determined by analysis of tail DNA on a slot blot (Schleicher
and Schuell, Keene, NH) using a radiolabeled C
 
d
 
 cDNA probe.
Hybridization signals were quantified relative to previously iden-
tified single copy integrants using a Betascope (Betagen, Wal-
tham, MA).
 
Preparation and Analysis of Genomic DNA.
 
Genomic DNA prep-
aration, PCR, gel electrophoresis, blotting onto nylon membranes
(Hybond-N; Amersham, Arlington Heights, IL or MAGNA ny-
lon; Micron Separations Inc., Westboro, MA), and hybridization
with 
 
32
 
P-labeled probes were performed as described previously
(13). The amount of DNA template used in PCR reactions (2–12
ng) was adjusted based on the results of amplification using C
 
d
 
primers to account for differences in transgene copy number and
PCR efficiency between samples, so that all PCR signals were
maintained in the linear range. TCR-
 
d
 
 minilocus PCR primers 1
(VD1), 2 (VD2), 3 (JD1), 4 (JD3), 5 (CDA), and 6 (CDB), as well
as the V
 
d
 
1, V
 
d
 
2, and C
 
d
 
 fragments used as probes to develop
Southern blots of PCR products or genomic restriction digests,
were described previously (13). These primers and probes allow
detection of human TCR-
 
d
 
 minilocus sequences, but do not al-
low detection of endogenous murine TCR-
 
d
 
 locus sequences.
Quantification of PCR signals was accomplished using either a 
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Betascope or a PhosphorImager (Molecular Dynamics, Sun-
nyvale, CA).
 
Results
 
An Intact CBF/PEBP2 Binding Site Is Necessary for Efficient
TCR-
 
d
 
 Gene Rearrangement In Vivo.
 
The previously studied
human TCR-
 
d
 
 gene minilocus is a 22.5-kb construct con-
taining germline V
 
d
 
1, V
 
d
 
2, D
 
d
 
3, J
 
d
 
1, J
 
d
 
3, and C
 
d
 
 gene seg-
ments, along with a wild-type version of E
 
d
 
 within the J
 
d
 
3-
C
 
d
 
 intron (13) (Fig. 1 
 
A
 
). The V
 
d
 
1 and V
 
d2 coding segments
carry mutations to prevent a rearranged transgene from en-
coding a TCR protein that might interfere with normal mu-
rine T cell development. Thus, the minilocus serves as a phe-
notypically neutral in vivo reporter of VDJ recombination.
For this study, we initially constructed a new version of
the minilocus, referred to as EdmCore, that carries a three–
basepair change in the dE3 core sequence within Ed (Fig.
1  A). The identical mutation was previously shown to
eliminate CBF/PEBP2 binding to dE3 in vitro, and to
eliminate transcriptional activation by Ed in transient trans-
fection experiments (25). Three transgenic founders, desig-
nated U, Y, and Z, were initially obtained. Breeding ex-
periments indicated that in each of founders U and Z, the
EdmCore minilocus was integrated at a single site in the
mouse genome, whereas in founder Y there were two in-
dependently segregating transgene integration sites. As a re-
sult, four different EdmCore transgenic lines (U, Z, Y1,
Y2) were established. As assessed by slot blot, the transgene
copy numbers were: U, 8 copies; Z, 3 copies; Y1, 1 copy;
and Y2, 2 copies. The single copy integrant in line Y1 was
truncated so as to delete z4–5 kb at the 39 end of the
minilocus. This truncation leaves Vd, Dd, Jd gene segments,
Ed and the first Cd exon intact, and as such, is not expected
to have a significant effect on minilocus VDJ recombination.
Analysis of wild-type and EdmCore minilocus VDJ re-
combination was performed by PCR from thymus ge-
nomic DNA templates, using specific Vd1, Vd2, Jd1, and Jd3
primers (primers 1, 2, 3 and 4; Fig. 1 C) as described previ-
ously (13). Previous studies have shown the wild-type
minilocus to rearrange stepwise, first V to D, and then VD
to J (13). Amplification with Vd and Jd1 primers yields 0.3-
kb fragments that represent complete VDJ rearrangements,
and in addition, 1.2-kb fragments that represent the VD re-
arrangement intermediates (Fig. 1 D). Amplification with
Vd and Jd3 primers yields 0.3-kb VDJ products only. PCR
reactions were also performed with a pair of Cd primers
(primers 5 and 6; Fig. 1 C), to control for differences in
transgene copy number and PCR efficiency between sam-
ples; the amount of genomic DNA template used in PCR
reactions was typically adjusted to obtain similar Cd ampli-
fication signals in each sample. PCR products were detected
and quantified by agarose gel electrophoresis followed by
blotting and hybridization with appropriate 32P-labeled
probes. In agreement with our previous studies (13), quanti-
fication of PCR signals revealed amplification to be linear
over a broad range of template concentrations (Fig. 2).
We analyzed the effect of the core site mutation on mini-
Figure 1. Structure and analysis of the Ed, EdmCore, and dE3,4 trans-
genes. (A) Schematic representations of the Ed and EdmCore minilocus
recombination substrates includes coding exons (filled boxes) and protein
binding sites within Ed (open boxes). The 3-bp substitution in the dE3 core
site is shown. (B) Schematic representation of the dE3,4 minilocus re-
combination substrate. (C) Primers used for analysis of minilocus rear-
rangement by PCR from genomic DNA (arrowheads). (D) Depiction of
PCR products generated from Vd1 rearrangements using primers 1, 3,
and 4. A similar set of PCR products are generated from Vd2 rearrange-
ments using primers 2, 3, and 4.1196 Regulation of TCR-d Gene Rearrangement by CBF/PEBP2
locus VDJ recombination by comparing VD and VDJ rear-
rangement levels in thymocytes from three previously char-
acterized lines of mice carrying a minilocus with a wild-type
Ed (A, B, C) (13) to thymocytes in the four lines of mice
carrying the EdmCore minilocus (Fig. 3, A and B). All Ed
lines of mice carry single copy integrations of the minilo-
cus. Whereas the minilocus integrations in lines A and B
include all relevant gene segments, the integration in line C
is truncated at the 59 end and is missing the Vd1 gene seg-
ment. Thus, lines A and B are informative for both Vd1 and
Vd2 rearrangement, whereas line C is informative for Vd2
rearrangement only. As in previous studies, PCR analysis of
VDJ recombination in the Ed lines revealed high levels of
0.3-kb VDJ rearrangement products in each case (Fig. 3, A
and B). Levels of 1.2-kb VD rearrangement products were
lower and more variable (Fig. 3 A). Thus, as observed pre-
viously (13), the enhancer-dependent VD to J step of trans-
gene rearrangement occurs efficiently in each of the Ed
lines.
Analysis of VDJ recombination in the four EdmCore
lines revealed quite different results. In three of the lines
(U, Y1, and Z), 0.3-kb products representing VDJ rear-
rangement were barely detectable, even though 1.2-kb VD
rearrangement products were readily apparent (Fig 3, A
Figure 2. Quantification of
minilocus VDJ rearrangement.
Serially diluted samples of thy-
mus genomic DNA from Ed line
A were amplified by PCR using
primers 1 and 3 or primers 5 and
6, and Southern blots were de-
veloped using radiolabeled Vd1
and Cd cDNA probes. The Vd1-
Dd3-Jd1 (solid line) and Cd (dotted
line) hybridization signals were
quantified using a PhosphorIm-
ager. The results are expressed
log hybridization signal in arbitrary units versus log DNA concentration
in mg/ml. The second most concentrated DNA sample in this experi-
ment corresponds to the amount of DNA used for analysis of single copy
integrants in all subsequent experiments. Lower amounts of DNA were
used for multicopy integrants.
Figure 3. PCR analysis of Ed
and EdmCore minilocus rearrange-
ment. (A) Genomic DNA from
thymi of wild-type Ed mice from
lines A, B, and C, and from Edm-
Core mice from lines U, Y1, Z,
and Y2 were amplified by PCR
using primers 5 and 6 (top), primers
1 and 3 (middle) and primers 2 and
3 (bottom). Southern blots were de-
veloped using radiolabeled Cd, Vd1
or Vd2 cDNA probes. The mice
analyzed were A-26 (3 wk old),
B-29 (2 wk old), C-306 (6 wk
old), U-19 (5 wk old), Y1-83 (2
wk old), Z-92 (3 wk old), and Y2-
87 (2 wk old). (B) Genomic DNA
from the thymi of mice from lines A, U, Z, and Y2 were amplified by PCR using primers 5 and 6 (top), primers 1 and 4 (middle) and primers 2 and 4 (bot-
tom). The mice analyzed were A-866, U-339, Z-419 and Y2-280 (all 4 wk old).
and B). In the fourth line (Y2), VD and VDJ rearrange-
ment products were both detected at levels that were com-
parable to their representation in Ed lines. The analysis of a
second animal in each line (data not shown) yielded quite
similar results, arguing that these VDJ recombination phe-
notypes are stable and reproducible characteristics of the in-
dividual transgenic lines. Because PCR amplifications with
the Cd primer pair and with the Vd1-Jd1 primer pair were
shown to be linear over several orders of magnitude (Fig. 2)
we were justified in quantifying the level of VDJ recombi-
nation in the different lines by normalizing the Vd1-Jd1
PCR signal to the Cd PCR signal in each line. The levels
of VDJ recombination in lines U, Y1 and Z, each calcu-
lated as the mean of three independent determinations, were
found to be 0.8, 1.3, and 0.3%, respectively, of the level in
Ed line A, and 3.1, 4.9, and 1.2%, respectively, of the level
in Ed line B (Table 1). Similar quantification revealed VDJ
recombination in line Y2 to be 41.7% of the level in line
A, and 159.8% of the level in line B (Table 1).
The conclusions drawn from PCR analysis were con-
ﬁrmed through analysis of Vd1-Dd3 and Vd1-Dd3-Jd1 rear-
rangements by genomic Southern blot (Fig. 4). Ed line A
thymocytes displayed nearly undetectable germline Vd1 (1.0
kb), moderate Vd1-Dd3 rearrangement (0.9 kb), and sub-
stantial Vd1-Dd3-Jd1 rearrangement (1.7 kb). In accord with
the PCR data, Vd1-Dd3-Jd1 rearrangement was not de-
tected in lines U and Z, even though transgene copy was
higher in these lines than in Ed line A. Importantly, Vd1-
Dd3 rearrangement was readily detected in both lines, and
accounted for almost all of the  Vd1 signal in line Z. Al-
though the reduced sensitivity of genomic Southern blot
analysis as compared to PCR analysis does not allow an in-
dependent evaluation of the extent to which VDJ recombi-
nation is reduced in lines U and Z, the readily detectable
Vd1-Dd3 rearrangement demonstrates that the ratio of VD
to VDJ rearrangement has been dramatically perturbed in
these lines. As these results argue that the VD to J step of
transgene rearrangement has been speciﬁcally inhibited, they
provide strong support for the PCR data. Also in accord
with the PCR data, Vd1-Dd3 and Vd1-Dd3-Jd1 rearrange-1197 Lauzurica et al.
ments were both detected in line Y2. Thus, on the basis of
both PCR and genomic Southern blot analyses, we con-
clude that the enhancer-dependent step of minilocus rear-
rangement is dramatically and preferentially impaired in
three of the four EdmCore transgenic lines, but occurs
quite normally in the fourth line.
These results are reminiscent of our previous work ana-
lyzing VDJ recombination within a TCR-d minilocus lack-
ing Ed (13) or containing a disrupted binding site for c-Myb
(39). In four of five transgenic lines carrying the minilocus
construct lacking Ed, and in three of four transgenic lines
carrying the minilocus construct with a disrupted binding
site for c-Myb, inhibition of the VD to J rearrangement
step was almost complete. However, in each case one of
the transgenic lines displayed higher levels of VD to J rear-
rangement. Such heterogeneity in TCR-d minilocus trans-
genic lines in which Ea has been eliminated or inactivated
probably reflects the distinct properties of the different
transgene integration sites. We propose that in E2, Edm-
Myb, and EdmCore lines in which the VD to J step still oc-
curs, the minilocus has integrated adjacent to active regula-
tory elements that partially or completely supplant the need
for Ed. Heterogeneity of this magnitude has not been ob-
served in transgenic lines carrying an intact enhancer, as
VD to J rearrangement is efficient in three of three Ed lines
(Fig. 3) and four of four Ea lines (14). On the basis of the
phenotype displayed by the majority of EdmCore trans-
genic lines, we conclude that elimination of a functional
CBF/PEBP2 binding site within Ed has a dramatic effect
on the ability of Ed to provide the regional accessibility to
the VDJ recombinase that is required for efficient VDJ re-
combination in vivo.
Intact Binding Sites for CBF/PEBP2, c-Myb, and GATA-3
Are not Sufficient for Efficient TCR-d Gene Rearrangement In
Vivo. Previous in vitro binding and transient transfection
studies identified a functionally important binding site for
c-Myb that is within the dE3 element and adjacent to the
CBF/PEBP2 binding site (27), as well as two functionally
important binding sites for GATA-3 within the adjacent
dE4 element (40, 41). A 60-bp dE3,4 fragment of Ed con-
taining only these binding sites displays 20–50% of the ac-
tivity of the intact 1.4-kb Ed in transient transfection exper-
iments (25). Since CBF/PEBP2 (this study) and c-Myb (39)
were implicated as important regulators of VDJ recombina-
tion in vivo, we asked whether the combination of CBF/
PEBP2, c-Myb and GATA-3 binding sites within dE3 and
dE4 was sufficient to activate this process.
Therefore, the 60-bp dE3,4 fragment of Ed was intro-
duced into the TCR-d gene minilocus in place of Ed (Fig.
1 B). Three transgenic founders were obtained and were
used to generate independent lines of transgenic mice des-
ignated JA, JE, and JG. Slot blot analysis indicated trans-
gene copy numbers of 2, 1, and 24 for JA, JE, and JG, re-
spectively. As in Ed line C, the single copy dE3,4 line JE is
truncated such that it lacks Vd1 but retains Vd2. Hence, this
line is informative for Vd2 rearrangement only.
Analysis of wild-type Ed and dE3,4 minilocus VDJ re-
combination was performed by PCR as described above.
All three dE3,4 lines revealed dramatically reduced levels of
VDJ rearrangement as compared to Ed lines A, B, and C
(Fig. 5, A and B). In lines JA and JE, VDJ rearrangement
was essentially undetectable, whereas in line JG, VDJ rear-
rangement was detectable at reduced levels. Nevertheless,
VD rearrangement signals were readily detected by PCR in
all three lines, and were detected at particularly high levels
in line JA. Quantification of Vd1-Jd1 and Cd PCR signals
indicated that VDJ rearrangement in lines JA and JG were
reduced to 1.4 and 4.7%, respectively, of the level in Ed
line A, and to 5.2 and 17.9%, respectively, of the level in Ed
line B (Table 1). Analysis of Vd1-Dd3 and Vd1-Dd3-Jd1 re-
arrangements by genomic Southern blot confirmed that es-
sentially all copies of Vd1 were rearranged to Dd3 in line
JA, but that rearrangement was blocked at this stage (Fig. 4).
Table 1. VDJ Rearrangement in Ed, EdmCore, and dE3,4 
Transgenic Lines
Construct Line Vd1-Dd3-Jd1/Cd
Ed A (100)
B 26.1  6 11.1
EdmCore U 0.8 6 0.4
Y1 0.3 6 0.3
Z 1.3 6 0.8
Y2 41.7 6 7.8
dE3,4 JA 1.4 6 0.6
JG 4.7 6 2.6
The Vd1-Dd3-Jd1 and Cd hybridization signals were measured in three
independent experiments. In each experiment, the Vd1-Dd3-Jd1 signal
was normalized to the Cd signal, and the results are reported as the
mean 6 SD. VDJ recombination expressed as a percentage of VDJ re-
combination in line A.
Figure 4. Ed, dE3,4, and EdmCore minilocus rearrangement analyzed
by genomic Southern blot. A Southern blot carrying PstI plus EcoRI di-
gested tail (germline control) and thymus DNA samples from Ed line A,
dE3,4 lines JA and JG, and EdmCore lines U, Z, and Y2 was developed
with a radiolabeled 1.0 kb Vd1 genomic PstI fragment as a probe. The
mice analyzed were A-866, JA-81, JG-42, U-339, Z-352, and Y2-280
(all 4 wk old).1198 Regulation of TCR-d Gene Rearrangement by CBF/PEBP2
Although the low level of VDJ rearrangement detected in
line JG could not be confirmed due to both the limited
sensitivity of detection and the presence of comigrating
germline fragments in the tail DNA control, the results for
JG did suggest that PCR may have underestimated the
level of Vd1-Dd3 rearrangement in this line. Also of note is
the significant reduction in transgene copy number in thy-
mus relative to tail in this line (Fig. 4 and data not shown).
This most likely results from the rearrangement of Vd1 in
one copy of the tandemly arrayed transgene to Dd3 in an-
other copy, with deletion of intervening copies. In sum-
mary, on the basis of the dramatic inhibition of VD to J re-
combination detected in both PCR and genomic Southern
blot analyses, we conclude that the combination of CBF/
PEBP2, Myb, and GATA-3 binding sites contained within
dE3 and dE4 is not by itself capable of promoting the ac-
cessible chromatin configuration required for efficient minilo-
cus VDJ recombination.
Discussion
We previously documented enhancer-dependent VDJ re-
combination within a human TCR-d gene minilocus con-
struct in transgenic mice (13, 14), and have now begun to
address the mechanisms by which Ed exerts its effects on
VDJ recombination in this system. The data presented here
indicates that a mutation that destroys the binding site for
the transcription factor CBF/PEBP2 within the dE3 ele-
ment of Ed seriously compromises the ability of Ed to acti-
vate the VD to J step of minilocus rearrangement. Hence,
by binding to Ed, this or a very closely related factor plays a
crucial  role in the developmental activation of minilocus
rearrangement in vivo. We interpret the pattern of trans-
gene rearrangement in the presence or absence of a func-
tional Ed to indicate that a functional Ed is required to
promote the accessibility of Jd gene segments to the VDJ
recombinase within the transgenic minilocus. Although not
directly proven, we infer that a functional Ed is also re-
quired to promote Jd gene segment accessibility, and hence
VDJ recombination, within the endogenous TCR-d locus.
Our data therefore suggest strongly that CBF/PEBP2 fam-
ily transcription factors are likely to be important regulators
of TCR-d gene rearrangement at the endogenous TCR-d
locus in vivo. Nevertheless, formal proof for this notion
would require elimination of the Ed CBF/PEBP2 binding
site from the endogenous locus by homologous recombi-
nation.
CBF/PEBP2 was initially identiﬁed by virtue of its abil-
ity to bind to and activate transcription from polyoma virus
enhancer and the long terminal repeats of murine T lym-
photropic retroviruses (42, 43). Functional CBF/PEBP2
binding sites have been identiﬁed in the regulatory elements
of several cellular genes expressed in either the T lymphoid
or myeloid cell lineages (44–48), including the enhancers of
all four TCR genes (30, 33–36). CBF/PEBP2 is actually a
complex family of transcription factors, each of which is
composed of a DNA-binding a subunit and an associated b
subunit (29–31). Three distinct genes (aA, aB, and aC) en-
code related a subunits (30, 49–52), a separate gene encodes
a shared b subunit (29, 31), and additional complexity is in-
troduced by production of multiple a and b isoforms from
the individual genes (29–31, 53). Thus, any one of a num-
ber of CBF/PEBP2 species might be the crucial regulator
of TCR-d gene rearrangement in vivo. Although recent
analysis of CBF/PEBP2 aB null mice emphasizes a crucial
role for this particular factor in hematopoiesis, the early le-
thality and pleiotropic effects of this mutation preclude any
speciﬁc conclusions regarding a role in TCR-d gene rear-
rangement (37). A candidate regulator of TCR-d gene re-
arrangement would have to be expressed as early as the
CD42CD82 stage of thymocyte development, since the
endogenous TCR-d locus (54, 55) and our transgenic
minilocus (14) are both activated during this stage. Notably,
CBF/PEBP2 aA and aB are both expressed at highest levels
in the thymus and are both expressed in CD42CD82 thy-
mocytes (56). Thus, both of these factors have expression
patterns that would be consistent with a role in the activa-
tion TCR-d gene rearrangement and expression in vivo.
Related studies using the transgenic minilocus approach
have also implicated the transcription factor c-Myb in the
activation of TCR-d gene rearrangement in vivo (39). Hence
CBF/PEBP2 and c-Myb appear to synergize to activate
TCR-d gene VDJ recombination in vivo, much as they were
found to synergistically activate TCR-d gene transcription
Figure 5. PCR analysis of Ed and dE3,4
minilocus rearrangement. Genomic DNA from
thymi of wild-type Ed mice from lines A, B, and
C, and from dE3,4 mice from lines JA, JE, and
JG were amplified by PCR using primers 5 and 6
(top), primers 1 and 3 (middle) and primers 2 and 3
(bottom). Southern blots were developed using ra-
diolabeled Cd, Vd1, or Vd2 cDNA probes. The
mice analyzed were A-765 (4 wk old), B-31 (8
wk old), C-114 (4 wk old), JA-81 (4 wk old), JE-
101 (4 wk old), and JG-42 (4 wk old). (B) Ge-
nomic DNA from the thymi of mice from lines
A, JA, JE, and JG were amplified by PCR using
primers 5 and 6 (top), primers 1 and 4 (middle) and
primers 2 and 4 (bottom). The mice analyzed were
A-866, JA-81, JE-101, and JG-42 (all 4 wk old).1199 Lauzurica et al.
in transient transfection studies (27, 28). Nevertheless, our
results indicate that the combination of CBF/PEBP2, Myb,
and GATA-3 binding sites within dE3 and dE4 is not, by
itself, sufficient to promote the accessibility required for ef-
ficient activation of VDJ recombination within the TCR-d
gene minilocus. This suggests that additional cis-acting ele-
ments contained within the 1.4-kb Ed are crucial for this
process. Such elements may be contained within the 370-bp
fragment of Ed found to contain maximal enhancer activity
in transient transfection experiments. Analyses of truncated
forms of the enhancer suggest dE2, dE5, and dE6 as candi-
date cis-acting elements of Ed that might individually or in
combination increase the activity of the minimal enhancer by
two- to threefold (24, 25). Little is known about the identi-
ties of the factors that interact with these elements. Neverthe-
less, it may be misleading to identify candidate determinants
of Ed recombinational enhancer activity in a chromosomally
integrated context in transgenic mice by extrapolating from
those required for transcriptional enhancer activity in tran-
sient transfection experiments. For example, nuclear matrix
attachment sites that flank Em are irrelevant for transcrip-
tional activity as measured in transient transfection experi-
ments or in chromosomally integrated substrates in stably
transfected cells, but are important for the induction of
transcriptional activity and general sensitivity to DNase I
digestion in a chromosomally integrated substrate in trans-
genic mice (57). Similarly sequences that flank the human
adenosine deaminase gene enhancer are irrelevant for tran-
scriptional activity in transient transfection experiments,
but are required for high level expression and the establish-
ment of enhancer DNase I hypersensitivity in transgenic
mice (58, 59). It is therefore quite possible that cis-elements
contained within the 1.4-kb Ed might not appear relevant
for gene expression on the basis of transient transfection ex-
periments, but might be critical for Ed induced accessibility
and VDJ recombination in transgenic mice. These addi-
tional cis-acting elements could be required for the stable
assembly of CBF/PEBP2, c-Myb, and GATA-3 onto their
dE3 and dE4 binding sites in a chromatin context. Alterna-
tively, dE3 and dE4 might by themselves be able to support
the assembly of a stable nucleoprotein complex, but addi-
tional cis-acting enhancer elements might contribute inde-
pendently to accessibility and VDJ recombination. The hi-
erarchy of assembly of nucleoprotein complexes at Ed, and
the mechanisms by which assembled nucleoprotein com-
plexes modulate regional chromatin accessibility and VDJ
recombination, will be important issues to address in future
studies.
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